Janone confirms stability data of jan101 development batch

Janone confirms stability data of jan101 development batch and prepares for commercial gmp production to support the upcoming pad and potential covid-19 clinical trials.janone inc - currently on track to initiate gmp production of jan101 to support planned phase 2b trials to treat peripheral artery disease.janone inc - remains on track for its pad phase 2b clinical trials expected to begin in early 2021.janone inc - expected that ind for jan101 as a covid-19 vascular complication treatment will be submitted to fda in coming weeks.janone inc - bottling and labeling of clinical trial batches are expected to begin in early october led by eurofins cdmo.janone - alphora research inc., will work with co's clinical teams, manufacturing partner to ensure integrity of all active, placebo bottles of jan101.janone inc - currently finalizing its covid-19 vascular treatment investigational new drug application for submission to fda.
JAN Ratings Summary
JAN Quant Ranking